Delivery Order SPE2DB20D3103-SPE2DB22FP0V4
Award Date
6/30/22
Potential Completion Date
7/1/22
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,159.26 firm-fixed-price delivery order is for the supply of 4566199384 - CEFEPIME-DEXTROSE 1 GM/50 MLS, a pharmaceutical product. This award is not associated with any set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of CEFEPIME-DEXTROSE 2 GM/50 MLS medical supplies. The $13,965.55 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 7, 2023. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $15,866.68 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product, with a period of performance through June 10, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of CEFEPIME-DEXTROSE 2 GM/50 MLS. The $2,668.35 firm-fixed-price delivery order contract has a period of performance through July 30, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a $3,772.27 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The order is for 4,565,322,209 units of the pharmaceutical product CEFEPIME-DEXTROSE 2 GM/50 MLS. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military...
This federal contract award, valued at $1,038.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4566449785 CEFEPIME-DEXTROSE 2 GM/50 MLS, a medical product, with a completion date of November 18, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated with a Set-Aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,813.60 firm fixed-price delivery order is for the supply of Cefepime-Dextrose 2 gram/50 mL, a critical antibiotic medication. The contract has an ultimate completion date of October 29, 2024 and was awarded on October 28, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,717.32, is for the delivery of Cefepime-Dextrose 2 GM/50 MLS, a pharmaceutical product, with a performance period ending on January 25, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,328.77 firm fixed-price delivery order is for the procurement of CEFEPIME-DEXTROSE 1 GM/50 MLS, a medication used in the treatment of infections. The award has an ultimate completion date of September 26, 2023 and was not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Cefepime HCL 2 gram vials, a pharmaceutical product. The $8,175.23 fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with a period of performance through May 30, 2024. The contract is a delivery order and does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...